Abiopharma

ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Arcutis Enrolls First Child in INTEGUMENT-INFANT EvaluatingZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS

TruBridge, Inc.: TruBridge Announces Participation in the Truist Securities Healthcare Disruptors & Digital Health Conference

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

Masimo - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization